在全医疗系统实施统一胸科ERAS方案后解剖性肺切除的结局
该前瞻性队列研究在一个医疗系统内(2019年1月至2023年3月)评估胸科加速康复外科(ERAS)方案对择期解剖性肺切除术后结局的影响,方案于2021年5月1日实施。共纳入1007例患者,其中450例(44.7%)为ERAS后组。实施后组在风险校正后任何并发症、呼吸系统并发症、肺炎、手术部位感染、心律失常、感染、阿片类药物使用、ICU使用率均较低,术后住院时间更短(均P<0.05)。
要点
- 胸科ERAS方案实施后,风险校正的总体并发症及多项具体并发症发生率均降低(均P<0.05)。
- 实施后组阿片类药物使用和ICU使用减少,术后住院时间缩短(均P<0.05)。
- 该研究验证了ERAS学会/欧洲胸外科医师学会指南,并表明多医院同步实施可行且有效。
核心结论
- 在整个医疗系统实施基于证据的胸科ERAS方案后,术后结局得到改善。
- 该研究验证了ERAS学会/欧洲胸外科医师学会指南,并表明多医院同步实施可行且有效。
研究设计与样本
- 前瞻性队列研究,在一个医疗系统内进行(2019年1月至2023年3月),共纳入1007例择期解剖性肺切除患者,其中450例(44.7%)为ERAS后组。
- 胸科ERAS方案于2021年5月1日实施,通过电子健康记录和Vizient数据追踪术后结局。
- 主要结局为总体并发症;次要结局包括个体并发症、住院时间、阿片类药物使用、胸管留置时间和总费用。
- 采用独立t检验、χ²检验或Fisher精确检验进行双变量比较,并采用多因素logistic回归控制混杂因素。
主要发现
- 实施后组风险校正后的任何并发症发生率较低(P<0.05)。
- 实施后组风险校正后的呼吸系统并发症、肺炎、手术部位感染、心律失常和感染发生率均较低(均P<0.05)。
- 实施后组阿片类药物使用和ICU使用率较低(均P<0.05)。
- 实施后组术后住院时间较短(P<0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We sought to evaluate how implementing a thoracic enhanced recovery after surgery (ERAS) protocol impacted surgical outcomes after elective anatomic lung resection. BACKGROUND: The effect of implementing the ERAS Society/European Society of Thoracic Surgery thoracic ERAS protocol on postoperative outcomes throughout an entire health care system has not yet been reported. METHODS: This was a prospective cohort study within one health care system (January 2019-March, 2023). A thoracic ERAS protocol was implemented on May 1, 2021 for elective anatomic lung resections, and postoperative outcomes were tracked using the electronic health record and Vizient data. The primary outcome was overall morbidity; secondary outcomes included individual complications, length of stay, opioid use, chest tube duration, and total cost. Patients were grouped into pre-ERAS and post-ERAS cohorts. Bivariable comparisons were performed using independent t -test, χ 2 , or Fisher exact tests, and multivariable logistic regression was performed to control for confounders. RESULTS: There were 1007 patients in the cohort; 450 (44.7%) were in the post-ERAS group. Mean age was 66.2 years; most patients were female (65.1%), white (83.8%), had a body mass index between 18.5 and 29.9 (69.7%), and were ASA class 3 (80.6%). Patients in the postimplementation group had lower risk-adjusted rates of any morbidity, respiratory complication, pneumonia, surgical site infection, arrhythmias, infections, opioid usage, ICU use, and shorter postoperative length of stay (all P <0.05). CONCLUSIONS: Postoperative outcomes were improved after the implementation of an evidence-based thoracic ERAS protocol throughout the health care system. This study validates the ERAS Society/European Society of Thoracic Surgery guidelines and demonstrates that simultaneous multihospital implementation can be feasible and effective.
引用
- Dyas AR, Stuart CM, Bronsert MR, et al. Anatomic Lung Resection Outcomes After Implementation of a Universal Thoracic ERAS Protocol Across a Diverse Health Care System. Ann Surg. 2024. PMID: 38385282. doi:10.1097/SLA.0000000000006243
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。